A combination of tacrolimus and mycofenolat mofetil after non-myeloablative unrelated matched donor allogeneic blood stem cell transplantation

被引：0
|
作者：
Zohren, F. [1 ]
Fenk, R. [1 ]
Graef, T. [1 ]
Czibere, A. [1 ]
Pape, H. [1 ]
Safaian, N. [1 ]
Kondakci, M. [1 ]
Germing, U. [1 ]
Haas, R. [1 ]
Kobbe, G. [1 ]
机构：
[1] Univ Dusseldorf, D-4000 Dusseldorf, Germany
来源：
BONE MARROW TRANSPLANTATION | 2007年 / 39卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [1] A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation
    Kornblit, Brian
    Maloney, David G.
    Storer, Barry E.
    Maris, Michael B.
    Vindelov, Lars
    Hari, Parameswaran
    Langston, Amelia A.
    Pulsipher, Michael A.
    Bethge, Wolfgang A.
    Chauncey, Thomas R.
    Lange, Thoralf
    Petersen, Finn B.
    Huebel, Kai
    Woolfrey, Ann E.
    Flowers, Mary E. D.
    Storb, Rainer
    Sandmaier, Brenda M.
    HAEMATOLOGICA, 2014, 99 (10) : 1624 - 1631
  • [2] Tacrolimus, Mini-Methotrexate and Mycophenolate Mofetil Is Safe and Effective as Acute Gvhd Prophylaxis for Non-Myeloablative Unrelated Donor Allogeneic Stem Cell Transplantation.
    Hong, Sanghee
    Martin, Thomas
    Damon, Lloyd E.
    Kaplan, Lawrence
    Navarro, Willis H.
    Linker, Charles
    BLOOD, 2009, 114 (22) : 481 - 481
  • [3] Kinetics of engrafting donor cells after non-myeloablative allogeneic stem cell transplantation
    Carella, AM
    Corsetti, MT
    Beltrami, G
    Greco, MM
    Scalzulli, PR
    Carella, AM
    BONE MARROW TRANSPLANTATION, 2003, 31 : S149 - S149
  • [4] Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation
    Junghanss, C
    Storb, R
    Maris, MB
    Carter, RA
    Sandmaier, BM
    Maloney, DG
    McSweeney, PA
    Corey, L
    Boeckh, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (04) : 662 - 670
  • [5] Pseudothrombocytopenia after allogeneic non-myeloablative stem cell transplantation
    Gillis, S
    Eisenberg, ME
    Shapira, MY
    Or, R
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (09): : 671 - 673
  • [6] Donor erythroid chimerism in mice after non-myeloablative allogeneic stem cell transplantation.
    Iannone, R
    Luznik, L
    Engstrom, LW
    Fuchs, EJ
    BLOOD, 1999, 94 (10) : 320B - 321B
  • [7] Donor cell leukemia after non-myeloablative allogeneic stem cell transplantation:: A single institution experience
    Ruiz-Arguelles, Guillermo J.
    Ruiz-Delgado, Guillermo J.
    Garces-Eisele, Javier
    Ruiz-Arguelles, Alejandro
    Perez-Romano, Beatriz
    Reyes-Nunez, Virginia
    LEUKEMIA & LYMPHOMA, 2006, 47 (09) : 1952 - 1955
  • [8] Non-myeloablative transplantation with or without T-cell depletion in unrelated donor stem cell transplantation
    Hyun, S. Y.
    Kim, S. J.
    Kim, Y. D.
    Kim, Y.
    Kim, J. S.
    Cheong, J. W.
    Min, Y. H.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S117 - S118
  • [9] Successful donor chimerism following unrelated donor stem cell transplantation for α-thalassemia after a non-myeloablative preparative regimen
    O'Brien, TA
    Wagner, JE
    Abel, S
    Ramsay, NKC
    Baker, KS
    PEDIATRIC RESEARCH, 2003, 53 (04) : 302A - 302A
  • [10] Non-myeloablative stem cell transplantation - High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation
    Passweg, JR
    Meyer-Monard, S
    Gregor, M
    Favre, G
    Heim, D
    Ebnoether, M
    Tichelli, A
    Gratwohl, A
    BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 267 - 271
12345